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Abstract: Advanced biomaterials and sophisticated processing technologies aim to fabricate 
tissue-engineering scaffolds that can predictably interact within a biological environment at a 
cellular level. Sterilization of such scaffolds is at the core of patient safety and is an important 
regulatory issue that needs to be addressed prior to clinical translation. In addition, it is crucial 
that meticulously engineered micro- and nano- structures are preserved after sterilization. 
Conventional sterilization methods involving heat, steam and radiation are not compatible with 
engineered polymeric systems because of scaffold degradation and loss of architecture. Using 
electrospun scaffolds made from polycaprolactone (PCL), a low melting polymer, and 
employing spores of Bacillus atrophaeus as biological indicators, we compared ethylene oxide, 
  
 
autoclaving and 80% ethanol to a known chemical sterilant, peracetic acid (PAA), for their 
ability to sterilize as well as their effects on scaffold properties. PAA diluted in 20% ethanol to 
1000 ppm or above, sterilized electrospun scaffolds in 15 min at room temperature while 
maintaining nano-architecture and mechanical properties. Scaffolds treated with PAA at 5000 
ppm were rendered hydrophilic, with contact angles reduced to zero degrees. Therefore, PAA 
can provide economical, rapid and effective sterilization of heat-sensitive polymeric electrospun 
scaffolds used in tissue-engineering.  
 
Keywords: Peracetic acid, sterilization, polymeric scaffolds, electrospinning, Bacillus atrophaeus 
spores. 
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INTRODUCTION 
 
 Tissue-engineering is a rapidly evolving field that aims to develop functional tissue 
substitutes by integrating advanced engineering principles and improved understanding of cell 
behavior. The ultimate goal of tissue-engineering and regenerative medicine is to improve the 
quality of life in patients by promoting true regeneration of structure and function of tissue 
compromised by disease or surgery [1]. Scaffold-based tissue-engineering is a popular strategy 
that involves the seeding and culture of specific cell types in an environment that mimic the 
native extracellular matrix (ECM). The ideal ECM analogs are engineered to be 3D instructional 
matrices that possess the physical, chemical and biological cues to promote tissue repair and 
regeneration [2] 
Metals and alloys, ceramics and polymers, either alone or in combination have been 
traditionally used to rehabilitate patients with failing or removed organs. While metals and 
ceramics are inherently strong and may possess favorable mechanical properties for orthopedic 
applications, they are designed to be non-degradable and possess limited processability. 
Polymers are being increasingly used in tissue-engineering because they are biocompatible, can 
be rendered biodegradable (by imparting appropriate chemistry), do not elicit host immune 
reactions (unlike natural polymers) and can be mass produced with little batch-to-batch 
variability. In addition, their composition, structure, mechanical properties and degradation rates 
can be tailored to suit specific needs [3]. Polycaprolactone (PCL) is a synthetic polymer, placed 
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on the FDA’s generally regarded as safe (GRAS) list, exhibits excellent biocompatibility, 
complete degradation in vivo and has been approved for drug delivery and medical devices 
applications.  PCL has been successfully used as micro- and nano- spheres in controlled drug 
delivery systems [4-6]; in sutures as a co-polymer with glycolide (Monacryl® by Ethicon); as a 
root canal filler [7]; and in tissue-engineering applications [8, 9].  
Among different techniques available to generate 3D porous polymeric scaffolds, 
electrospinning is a versatile technique that consistently reproduces the sub-micron fibrous 
morphology of the native ECM. The process involves dissolving a biodegradable polymer in an 
organic solvent at high concentrations and subjecting this viscous solution to high voltage (tens 
of kilovolts). At a critical voltage, the electrostatic charge overcomes the surface tension of the 
polymer drop and polymer chains entangle to form a stable jet. As the charged jet travels towards 
a grounded target under the influence of electric field, the solvent evaporates and the fibers are 
collected as dry, fibrous, non-woven mats. The scaffold composition, fiber diameters and 
alignment can be readily controlled by the operator to tailor tissue-specific properties [10]. 
Tissue engineered products are devices intended to be in direct contact with living tissue 
and are regulated by the FDA for safety and efficacy. One of the fundamental requirements for 
such a device is the need to be completely sterile (and not merely disinfected) prior to 
implantation. The Center for Disease Control defines sterilization as a process that destroys or 
eliminates all forms of microbial life while disinfection describes a process that eliminates many 
or all pathogenic microorganisms, except bacterial spores, on inanimate objects [11]. Hence it is 
imperative that an appropriate sterilization method is chosen to ensure safety as well as maintain 
material properties and preserve engineered micro- and nano-scaled features of polymeric 
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scaffolds. Current sterilization processes employed by the health care industry, including 
autoclave, gamma irradiation and ethylene oxide, cannot be readily applied to tissue engineered 
products because of the biomaterial involved i.e. synthetic polymers. Polyesters are the most 
widely used class of polymers because of their biocompatibility and biodegradability. However, 
being hydrolytically unstable, they cannot be subjected to moist heat (autoclaving); high energy 
gamma radiation degrades polymeric backbone, reduce molecular weight and alter degradation 
profiles [12]. Ethylene oxide (EtO) alters scaffold properties by penetrating into polymeric 
networks and reacting with chemical groups [13].   
Given the translational nature of tissue-engineering research and constant innovation in 
polymer systems and their processing technologies, the issue of sterilization needs to be 
periodically revisited. In this study, we systematically explore the feasibility of using peracetic 
acid (PAA) as a chemical sterilant for polymeric tissue-engineered scaffolds and compared it 
with two accepted methods of sterilization (EtO and autoclaving) and a high-level disinfectant 
(80% ethanol). We included the latter because of its widespread use in tissue engineering studies. 
We chose a widely used polymer, PCL, to represent polymers with low melting points and 
electrospun it to produce porous 3D scaffolds with defined nano-topography. Our aim was to 
identify the process conditions (concentration, contact time and temperature) necessary to 
achieve sterility while maintaining scaffold integrity. Since spores are routinely used as 
biological indicators for sterilization [14],  we inoculated electrospun scaffolds with spores of 
Bacillus atrophaeus and exposed them to different sterilization treatments. To our knowledge, 
this is the first study to evaluate the effectiveness of sterilization using spores as biological 
indicators in the context of electrospun polymeric scaffolds. In addition to assaying spore 
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survival, the effects of sterilization processes on scaffold properties including fiber morphology, 
permeability, hydrophilicity and tensile modulus were evaluated. 
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MATERIALS AND METHODS 
 
2.1. Electrospinning: PCL (Sigma, MW 80,000, melting point 59-64
o
C) was dissolved in 
1,1,1,3,3,3-hexafluro-2- isopropanol (HFP, Oakwood Products, SC) at a concentration of 100 
mg/ml. Electrospinning apparatus (EC-DIG, IME Technologies, Netherlands) was used to 
generate nanofibers. Process conditions were optimized (rate: 7 ml/h, air-gap distance: 12.5 cm, 
applied needle voltage: +25 kV) to generate continuous non-woven fibers that were collected 
onto a rotating cylindrical drum mandrel (100 mm diameter at 1000 rpm). After electrospinning, 
scaffolds were removed from the mandrel, dried in a fume hood for 30 min and stored in an 
airtight desiccator until use. Electrospun PCL (e-PCL) scaffolds were cut using dermal biopsy 
punches (Acuderm, FL) for use in experiments.  
2.2. Characterization of B. atrophaeus Spores:  B. atrophaeus spores (ATCC #9372) were 
purchased as suspensions in 20% ethanol (10
8
/ml) from Moog Medical Devices Group, NY and 
stored at 4
o
C. A total of 10
6
 spores were diluted in 1 ml of de-ionized water (DI water) and two 
subsequent (1:50) serial dilutions were plated on TSA (tryptic soy-agar) plates using the 
EddyJet2 Spiral Plating System (NeuTec Group, NY).  The plates were then transferred to the 
incubator at 35
o
C and checked for colonies after 18 h.   
2.3. Sterilization Efficacy of Peracetic Acid (PAA): PAA was purchased as a 39% solution 
(Sigma) in acetic acid and hydrogen peroxide. Different concentrations of PAA (100, 500, 1000, 
2500 and 5000 ppm) were obtained by diluting the stock (390,000 ppm) in appropriate volume of 
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DI water. Initial experiments to identify the minimal effective concentration were done by 
directly exposing the spore suspensions to different concentrations of PAA for 5 minutes at room 
temperature, plating these solutions on solid agar and evaluating colonies, as described in 2.2. 
Absence of colonies is a more important parameter while assessing terminal sterilization since 
their evidence represents a failure to achieve sterility. Thus, the actual numbers of colonies are 
irrelevant and were not recorded. For experiments involving scaffolds, a second diluent was 
introduced; in addition to DI water, the PAA was also diluted in 20% ethanol. This is because we 
observed significantly better wetting of spore solution (in 20% ethanol) on scaffolds than DI 
water. 
2.4. Scaffold Inoculation with B. atrophaeus Spores and Culture: Our goal was to inoculate 
10
6
 spores onto each 10 mm disc of e-PCL fabric. We observed poor loading of spores onto 
scaffolds when used as dilute solution (as described in 2.2) and hence chose to inoculate without 
dilution (10 µl spore suspension). Circular discs, placed into 24-well microplate, were inoculated 
with 10
6
 spores and allowed to dry for 30 min. These spore-laden scaffolds were then subjected 
to different methods of sterilization (described in section 2.6). At the end of defined sterilization 
cycle, scaffolds were transferred into 5 ml of tryptic soy broth (TSB) and cultured in a 
mechanical shaker for 3 days at 35
o
C. Turbidity of the broth indicated bacterial growth and was 
interpreted as an indicator of inadequate sterilization.  
2.5. Scanning Electron Microscopy: Air-dried electrospun scaffolds (before and after various 
sterilization protocols) were mounted on aluminum stubs using standard double-sided tape, 
sputter coated with gold and examined at an accelerating voltage of 20 kV using JEOL JSM 
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5610LV scanning electron microscope. Average fiber diameters were calculated from a total of 
50 randomly selected fibers from corresponding SEM images using Image J (NIH). 
2.6. Sterilization Treatment and Efficacy Testing of Electrospun Scaffolds:   Dry, spore-
laden PCL scaffolds were subjected to 6 different sterilization regimens: ethylene oxide (EtO); 
autoclaving; 80% ethanol; 1000 ppm, 2500 ppm and 5000 ppm of peracetic acid (PAA).  EtO 
sterilization was carried out at 50
o
C for 16 h (including aeration time), while autoclaving was 
performed at 121
o
C at 15 psi for 15 min. Scaffolds for these treatments were placed in self-
sealing pouches (Henry-Schein) containing appropriate chemical indicators to verify that 
conditions for sterilization were met. Scaffolds for ethanol treatment were immersed in an 80% 
solution (in DI water) for 30 min and rinsed three times with PBS for 10 min per wash. Stock 
solution of PAA was diluted in either DI water or 20% ethanol solution (in DI water) to prepare 
different concentrations and PCL scaffolds incubated for 15 min at room temperature on an 
orbital shaker. The contact times was increased from 5 minutes (section 2.3) to account for 3D 
nature of the scaffold and allow adequate time for PAA to infiltrate the porous network and come 
in contact with the spores. Scaffolds treated with each sterilization regimen, as well as untreated 
controls, were then transferred into 5 ml of tryptic soy broth (TSB) and cultured in a mechanical 
shaker for 3 days at 35
o
C. Again, an increase in culture turbidity, due to bacterial growth, was 
used as an indicator of inadequate sterilization.  
2.7. Contact Angle Measurements:  Changes in surface properties of e-PCL scaffolds (treated 
and controls) were determined by measuring the contact angle using a Rame´-Hart 200 contact-
angle goniometer. A sessile drop (2-4 µl volume) of DI water was placed on the surface of the 
scaffold using a micro-syringe and allowed to equilibrate for a period of 10 sec. The image of the 
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drop was captured and analyzed using DROPImage (Rame´-Hart Instrument, NJ) for contact 
angle measurements. A total of 6 readings were performed for each scaffold type. 
2.8. Scaffold Permeability:  A modification of flow meter developed in our laboratory and 
described previously [15] was used to calculate scaffold permeability. Instead of a steady 
hydrostatic pressure (provided by an elevated reservoir) and gravity-assisted flow, we adapted a 
micro-filtration assembly (EMD Millipore Corporation, MA) and employed suction to provide 
the driving force for filtration. Electrospun scaffolds were cut into 25 mm circular discs and their 
thickness recorded using a micrometer (Mitutoyo America Corporation, IL). Scaffolds were 
placed on top of a Type 316 stainless steel screen (100 mesh, filtration area of 2.1 cm
2
), edges 
sealed using clear PTFE gaskets and the attachment secured to a 300 ml borosilicate glass funnel 
using an anodized aluminum clamp. The apparatus was attached to a vacuum pump that 
generated a suction of 25 inches mercury (corresponds to approximately 4.9 inches mercury of 
positive pressure). The funnel was filled with 300 ml DI water and the time required for 50 ml to 
flow through the membrane was recorded. Scaffold permeability was calculated from an average 
of 4 readings (for each scaffold type) and used in Darcy’s equation (τ =Qηhs/Ftp), where, τ 
represents scaffold permeability in darcy units (d), Q is the fluid volume passed through the 
scaffold in time t, η is the viscosity (0.89 cp for water at 25oC), hs is scaffold thickness, F is the 
filtration area and p is the applied pressure. 
2.9. Uniaxial Tensile Testing: Uniaxial tensile testing was performed according to our previous 
published studies [16] . Briefly, scaffolds from each group (n=6) were punched into ‘dog-bones’ 
(2.75 mm wide at their narrowest point with a gage length of 7.5 mm) and tested on an MTS 
Bionix 200 testing system with a 50 N load cell (MTS Systems Corp.) at an extension rate of 
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10.0 mm.min
−1
 . Elastic modulus, strain at break and energy to break were calculated and 
recorded by MTS TestWorks 4.0.  
2.10. Stability of Peracetic Acid: PAA was prepared in different concentrations from 100-2000 
ppm in DI water as well as 20% ethanol solution and stored air-tight at room temperature for up 
to 3 weeks. The solutions were subsequently tested for PAA concentration every 3 d using 
colorimetric MQuant™ test strips specific for peracetic acid and sensitive in 100-2000 mg/L 
(ppm) range (EMD Millipore, Germany).  Manufacturers’ instructions were followed to test 
PAA concentrations and any changes over time were recorded.  
2.11. Statistical Analysis: Values were presented as means and standard deviation where 
appropriate. The scaffold types were compared using ANOVA and significant differences were 
described using Tukey’s HSD. All analyses were performed using SAS software (JMP version 
10, SAS Institute Inc., Cary NC). 
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RESULTS 
 
3.1. Electrospun Scaffold and Spore Characterization: Porous, nanofibrous scaffolds were 
generated following optimization of electrospinning conditions. SEM analyses revealed the 
average fiber diameter was 0.92±0.52 µm. There was a broad distribution of fibers with fiber 
diameters ranging 136 nm to 2100 nm. SEM of spores showed typical rod-shaped structure, with 
the smaller dimension less than 1 µm, size was small enough to penetrate into the depths of 
porous fibrous matrix (Figure 1). Spores loaded onto scaffolds could not be visualized even at 
high concentrations, possibly due to the porous nature of electrospun scaffolds as well as lack of 
color contrast. 
3.2. B. atrophaeus Spore Culture and Sensitivity to PAA: Untreated spores promptly 
germinated on the surface of TSB agar to form discrete reddish-orange colonies within 18 h 
(Figure 2). Longer incubation times led to coalescence and difficulty distinguishing individual 
colonies. Exposure of spore suspensions to PAA (diluted in DI water) resulted in marked 
reductions in colony forming units. The number of colonies decreased significantly at 100 ppm 
(visual) but isolated colonies could still be seen at 500 ppm. However, no colonies were found at 
1000 ppm or above. Figure 3 is representative of the results obtained with 3 trials. Hence, we 
established that 1000 ppm was the minimal sporicidal concentration of PAA at room 
temperature.  
3.3. Effects of Sterilization: 
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For each of the sterilization treatments on e-PCL scaffolds, we validated the sterilization process 
using the spores of B. atrophaeus as a biological indicator. In addition, we investigated the 
effects of the process on the physical and mechanical properties of the scaffolds. The results are 
discussed in the same order. 
3.3.1. Sterilization Efficacy: 
Both EtO and autoclaving are established methods of sterilization and expectedly destroyed all 
spores. Scaffolds treated with 80% ethanol demonstrated heavy bacterial loads similar to 
untreated controls. This is not surprising given that 80% ethanol is a high-level disinfectant 
incapable of killing spores and hence is not a viable option for terminal sterilization. Since 1000 
ppm was identified to be the minimal sporicidal concentration of PAA, lower concentrations 
(100 and 500 ppm) were ignored and assays on e-PCL scaffolds were performed with 1000, 2500 
and 5000 ppm only. Spore-inoculated scaffolds, challenged to different concentrations of PAA 
diluted in DI water, showed incomplete sterilization even at 1000 and 2500 ppm (data not 
shown). Lack of efficacy at these sporicidal concentrations was attributed to inadequate wetting 
of PCL scaffold and resultant decreased access of PAA to spores within the scaffold. In order to 
improve the wetting characteristics of hydrophobic polymer scaffold, PAA was diluted in 20% 
ethanol, the same solution in which the spores were originally suspended. This modification 
dramatically improved the efficacy of PAA demonstrated by complete sterilization at 1000 ppm 
and above, consistent with our earlier observation with spore suspensions (Figure 4).  
3.3.2: Effects of sterilization methods on physical and mechanical properties:  
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3.3.2a. Gross Morphology and SEM: EtO treated electrospun scaffolds showed minimal gross 
dimensional change, but the scaffolds became translucent and brittle. Autoclaving induced 
massive melting and coalescence of polymer and completely destroyed the integrity of the 
scaffold. Further, scaffolds subjected to EtO and autoclaving showed complete loss of fibrous 
architecture and fusion of independent fibers under SEM (Figure 5). Scaffolds treated with 
chemical sterilants (80% ethanol and different concentrations of PAA) did not show any 
appreciable change in either macroscopic (photographic imaging) or microscopic (SEM) scale 
compared to controls.  
The scanning electron micrographs of scaffolds treated with PAA diluted in DI water and 20% 
ethanol are shown in Figure 6. The fibrous morphology of the scaffolds was significantly altered 
by treatment with PAA diluted in DI water in a concentration-dependent manner; individual 
fibers started to fuse into bundles with evidence of fiber breakage at higher concentrations. PAA 
diluted in 20% ethanol showed a tendency towards thinning of fibers but preserved open porous 
architecture even at 5000 ppm. Statistical analyses confirmed significant effect of PAA 
concentration on fiber diameter depending upon the diluent (p < 0.001).  Scaffolds treated with 
PAA diluted in DI water showed a significant difference in fiber diameter (p < 0.001); fiber 
diameters at 2500 ppm and 5000 ppm were larger than all other concentrations but were not 
different from one another (2500 ppm mean = 2.03±1.02 µm vs. 5000 ppm mean = 1.82±0.81 
µm). Concentration-dependent effects on fiber diameter were not observed in scaffolds treated 
with PAA diluted in 20% ethanol (p > 0.8). 
 3.3.2b. Scaffold Hydrophilicity:  Contact angle measurements following different sterilization 
treatments were analyzed to indicate hydrophilicity or wettability of the scaffolds. Generally, 
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surfaces are termed hydrophilic when the water contact angle is less than 90
o
 and hydrophobic, if 
contact angle is more than 90
o
. Figure 7 shows representative image of an actual drop placed on 
differently treated surfaces. Untreated control PCL scaffolds are highly hydrophobic (contact 
angle around 120
o
); EtO, autoclaving and 80% ethanol treatments make them hydrophilic as seen 
by reduced contact angles. Scaffolds treated with PAA at 1000 and 2500 ppm, in either diluent, 
did not significantly alter the wetting properties. However, at 5000 ppm, there was a dramatic 
decrease in the contact angles. Figure 8 is quantitative representation of average of contact 
angles measured from 6 replicates for each scaffold type. Scaffolds treated with PAA at 5000 
ppm diluted in DI water decreased contact angles by more than half, whereas PAA in 20% 
ethanol completely soaked up the water and brought the contact angle to zero.  
3.3.2c. Scaffold Permeability: The permeability of the PCL scaffold to water was highest in the 
control untreated PCL scaffold and decreased with increasing concentrations of PAA until the 
effect plateaued  off at 2500 ppm (Figure 9, p<.001). The permeability of scaffolds treated with 
PAA at 2500 ppm was not significantly different than 5000 ppm, nor was it different than when 
using 80% ethanol.  This correlates well with the observation on scaffold hydrophilicity; a 
hydrophilic scaffold is expected to interact with water and decrease the flow rate. Scaffolds 
treated with PAA diluted in DI water demonstrated high variations in permeability, due to 
heterogeneity in wetting characteristics (data not shown).  
3.3.2d. Mechanical Properties:  Since PAA diluted in DI water were not sporicidal at high 
concentrations, induced unfavorable changes in fiber morphology and produced inconsistent data 
for scaffold permeability, we did not perform mechanical testing on these samples. The results of 
mechanical testing of scaffolds treated with 80% ethanol and different PAA concentrations are 
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shown in Figure 10. EtO and autoclaved samples could not be mechanically tested because of 
loss of scaffold integrity. It is interesting to note that the modulus was not affected by the 
concentration of PAA used (p > 0.06). Values for energy to break and strain at break indicate a 
tendency towards brittleness with increasing PAA concentrations up to 2500 ppm (statistically 
not significant). However, at 5000 ppm, the scaffolds were not statistically different from 
controls for the same properties (p = 0.007 and p = 0.010 respectively).  
3.4. PAA Stability: PAA is at equilibrium with acetic acid and hydrogen peroxide and is 
particularly unstable at low concentrations  [17]. PAA at 100 ppm started degrading around 7 
days as determined by visual comparison with manufacturer- provided shade guide. Higher 
concentrations of PAA (>200 ppm) did not show any degradation for a period of 3 weeks when 
stored air-tight at room temperature. In addition, stability of PAA was not affected by the diluent 
used. Hence, PAA at concentrations necessary for sterilization (> 1000 ppm) could be prepared 
in large volumes and stored for a minimum of three weeks.  
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DISCUSSION 
 
The aim of tissue-engineering is to develop viable functional alternatives for failing 
tissues and organs. However, the strategies pursued have evolved from purely cell- or 
biomolecule- based approaches to the current paradigm of scaffold-based tissue-engineering. 
This involves seeding and culturing specific cell types in engineered 3D matrices designed to 
simulate the ECM [2]. Such matrices are expected to present appropriate physical, biological and 
biochemical cues to predictably influence cell behavior [18, 19]. Synthetic polymers are widely 
used in tissue-engineering because they are biocompatible, biodegradable and can be tailored to 
possess a wide range of properties. The growing list of polymers [3, 20]  and emerging scaffold 
fabrication technologies [21],  provide matrices with a variety of internal architecture and 
mechanical properties.  
Intended to be in direct contact with living tissues, these scaffolds must be terminally 
sterilized prior to implantation. Product sterility cannot be assumed even if fabricated in a ‘clean 
room’ because the machinery and starting materials are not sterile. Moreover, normally benign 
bacteria can become pathogenic when present on the surface of devices  [22]. These factors make 
scaffold sterilization a vital issue to be resolved prior to clinical translation. Synthetic polymers 
used in tissue engineered scaffolds possess low melting points, are susceptible to hydrolysis and 
possess intricate architecture at micro-or nano- scale, all of which can be affected by the 
sterilization process. Mechanical and surface properties, toxicity and biocompatibility of 
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scaffolds can all be potentially altered by sterilization. Hence careful evaluation of scaffolds 
before and after sterilization is required to identify a sterilization method that is benign to the 
polymer, device and the patient [22]. In this context it is important to realize that standard 
sterilization practices (including autoclaving, ethylene oxide and use of high energy irradiation) 
are not specifically suited for polymeric systems employed in tissue-engineering. 
Autoclaving with pressurized moist steam at 120
o
C for 15 min is not a viable option for 
sterilizing polymers with low melting points. Further, most biocompatible polymers are 
hydrolytically unstable and exposure to moisture can accelerate degradation, reduce shelf life 
and alter mechanical properties [23]. EtO Is a reactive gas that can penetrate into polymeric 
networks, react with their chemical groups, cause polymer degradation and alter scaffold 
dimensions [24]. In addition, EtO is carcinogenic and needs to be extensively degassed over 
many hours prior to packaging [13]. High energy irradiation is an efficient sterilization method 
that may preserve the morphology of 3D scaffolds, but it dramatically decreases the polymer 
molecular weight and hence, accelerates degradation [11]. 
Limitations of conventional modes of sterilization in tissue-engineering have led 
researchers to explore alternatives, especially in the past few years. Shearer et al. [25] found that 
PAA and antibiotic solutions were effective in sterilizing hollow fiber and flat sheets of poly 
(lactide: glycolide) but induced unfavorable changes in morphology but not mechanical 
properties. Rainer et al. compared the effects of different sterilization techniques (ethanol, dry 
heat, autoclave, UV and plasma treatment) on morphology and crystallinity of electrospun poly-
l-lactide scaffolds [26]. Dry heat and autoclave treatments resulted in an increase in crystallinity 
while low temperature UV and hydrogen peroxide plasma preserved the structural properties. 
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Siritientong et al. [27] evaluated the effects of sterilization on lyophilized sericin-polyvinyl 
alcohol scaffolds and concluded that gamma irradiation was the most appropriate method even 
though it degraded the scaffolds by almost 70% in 24 h. These early studies were critically 
demonstrated that sterilization of tissue engineering scaffolds is as much about maintenance of 
material properties and architecture as it is about killing microbes. Sterilization assumes greater 
significance in scaffolds containing proteins or biologics where the risk of denaturation is real 
and can result in decreased or loss of vital biological activity.  
However, a common limitation in aforementioned studies included a lack of uniform 
model organism tested; many did not specify the source or the identity of the contaminating 
bacteria. In cases where known bacteria were used, there is no consistency in the choice of the 
bacterial species. In addition, some groups used unsterilized material as control which can vary 
widely in their bacterial load or bio-burden.  This makes comparison of sterilization methods in 
the context of tissue-engineering scaffolds difficult.  
In contrast, we adopted a standardized format to test sterilization of electrospun scaffolds 
in terms of microbe identity and number. Spores of B. atrophaeus were appropriately chosen as 
the model organism, considering their routine use (as biological indicators) to validate 
sterilization processes. We ensured a consistency in bio-burden by inoculating 10 mm discs of e-
PCL scaffolds with 10
6 
B. atrophaeus spores. We employed EtO and autoclaving as positive 
controls of sterilization and 80% ethanol because of widespread use in tissue engineering studies. 
We then systematically identified the process conditions for effective sterilization using PAA, a 
known chemical sterilant at room temperature. Varying the concentration, contact times, we 
were able to demonstrate that e-PCL scaffolds can be effectively sterilized using PAA without 
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subjecting them to harsh processes. This is especially important in the context of tissue-
engineering scaffolds because sterilization provides a higher standard of care as well as highest 
margin of safety for patients, compared with high-level disinfection. We reasoned that spores 
being the most resistant form of life [14] and present in large numbers on scaffolds, a negative 
spore test would indicate complete elimination of bio-burden [11] and a sterile scaffold.  
The use of chemical agents to reduce bacterial load in polymeric scaffolds is attractive 
because it allows processing at low temperatures and short duration. Peracetic acid has long been 
in use as a chemical sterilizing agent because of its strong oxidizing properties. It is available as 
an equilibrium mixture of acetic acid and hydrogen peroxide and has been extensively used in 
the food industry because of its high potency and low residual toxicity. PAA denatures proteins, 
disrupts cell wall permeability and is effective against all known microbes (including spores) 
even in the presence of organic matter [17, 28]. PAA is effective at low concentrations, low 
temperatures and reduced contact times compared with traditional methods.  PAA is also 
economical, degrades into non-toxic end products (water, oxygen and carbon dioxide) and can be 
safely disposed of without affecting the environment [11].  
The efficacy of PAA is affected by concentration, contact time, pH and temperature.  A 
commercially available system (Steris Corporation, OH) employs 35% PAA diluted to 200 ppm 
in water (pH 6.4), at 50-56
o
C for 23 min. This automated system has been approved for 
sterilizing medical, surgical and dental instruments including those made from heat-sensitive 
materials [29]. The STERIS system is optimized for sterilization at near neutral pH to reduce the 
tendency of PAA to corrode metals; hence the use of PAA at low concentrations (200 ppm). 
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We needed to significantly deviate from the FDA approved STERIS protocol to account 
for differences in materials being processed. First, since polymeric scaffolds are sensitive to heat 
(PCL degraded with EtO exposure at 50
o
C), our priority was to perform sterilization at room 
temperature. Second, in contrast to traditional solid surfaces (tubes and instruments), engineered 
scaffolds are three dimensional, nanofibrous and porous structures. The enormous surface to 
volume ratio offered by electrospun scaffolds is a huge advantage in tissue-engineering but also 
presents an opportunity for colonization and survival of spores/ bacteria in the depths of the 
scaffold. Third, the hydrophobicity of the polymer coupled with highly porous structure makes 
the scaffold difficult to be wet by PAA. It is known that the device should be completely 
immersed and all surfaces must be in direct contact with PAA for effective sterilization.  
Having established that 1000 ppm PAA killed spores in suspension within 5 min at room 
temperature, we extended the contact time to 15 min in experiments with scaffolds, taking into 
account their 3D porous structure. We also found that wettability of the scaffold affected the 
ability of PAA to kill spores. Since our model polymer (PCL) was hydrophobic, diluting PAA in 
water (as has been done in STERIS) yielded incomplete sterilization. However, use of 20% 
ethanol (in DI water) as diluent for PAA significantly improved the wetting characteristic of the 
scaffold and restored the efficacy of PAA at previously established concentrations. This finding 
reinforces the fact that PAA needs to be in physical contact with the surface to be effective. 
PAA at high concentrations (5000 ppm) also induced favorable surface properties on 
electrospun scaffolds. Control PCL scaffolds were significantly hydrophobic as reflected by very 
high contact angles. However, when scaffolds were treated with PAA at 5000 ppm, the scaffold 
surface became markedly hydrophilic. The extent of this effect was dependent on the diluent, 
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with contact angles dropping to zero when 20% ethanol was used. This was not unexpected 
because polyester polymers are known to undergo acid- or alkali- mediated hydrolysis resulting 
in increased hydrophilicity. Since hydrophilicity directly affects scaffold biocompatibility and 
favorable host response [30, 31], use of PAA offers the dual advantage of sterilization and 
inducing favorable surface properties.  
Since acid-mediated hydrolysis can potentially affect morphological characteristics and 
mechanical properties of electrospun scaffolds, we sought to evaluate these effects by SEM and 
tensile testing. We found that individual fibers tended to fuse and scaffolds demonstrated 
decreased porosity when PAA was diluted in DI water, yet no appreciable change occurred when 
PAA was diluted in 20% ethanol, even at 5000 ppm. In addition, mechanical properties were not 
significantly affected by the PAA treatment. 
The limitations of the current study include investigating the effects on one polymer type 
(PCL) processed by one fabrication technique (electrospinning) and hence cannot be generalized. 
PAA is a potent chemical agent that can sterilize any surface, yet its practicality needs to be 
ascertained for various polymers processed differently. Conditions for sterilization and effects on 
scaffolds will vary and need to be optimized for specific systems. Future work will investigate 
the biological response of PAA-sterilized scaffolds in vitro and in vivo. 
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CONCLUSIONS 
 
Our primary goal was identify to systematically evaluate the feasibility of using peracetic acid 
(PAA) as an alternative to conventional methods to effectively sterilize electrospun PCL 
scaffolds. We deliberately chose PCL because of its low melting point and electrospun it to 
confer defined nanoscale features, whose integrity can be followed during processing. We report 
that PAA at 1000 ppm (diluted in 20% ethanol) for 15 min at room temperature renders the 
scaffold sterile and at 5000 ppm dramatically alters the hydrophilicity of the scaffold as well. 
More importantly, these effects are observed while preserving the morphological and mechanical 
properties of the scaffold.  
Novel biomaterials (smart polymers, carbon nanotubes) and fabrication technologies 
(including electrospinning, solid freeform fabrication, stereolithography and 3D printing) are 
being introduced at rapid pace to develop tissue-specific scaffolds. Scaffold sterilization, though 
the last physical step in product processing should be at the forefront of scaffold development to 
ensure that neither the novel properties of biomaterials nor the nanoscale architecture that are 
painstakingly built are altered or lost. 
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Figure 1: SEM images of electrospun PCL scaffold and B.atrophaeus spores.  
 
 
 
Left: SEM of the e-PCL scaffold demonstrating the fibrous morphology and open porous 
structure. The mean fiber diameter was 0.92 µm. Right: SEM image of B. atrophaeus spores 
seeded directly on a double sided tape. The rod shaped spores are less than one micron in length. 
Scale bar is 5 µm in both images. 
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Figure 2: Optimization of B. atrophaeus spore culture. 
 
 
 
A total of 5 x104 spores were seeded onto solid agar plate (A).  Subsequent (1:50) serial dilutions 
are shown in (B) and (C). Discrete reddish-orange colonies were visible upon 18 h incubation at 
35oC. 
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Figure 3:  Effect of PAA (diluted in DI water) on spore viability. 
 
 
 
Spores were incubated with different concentrations of PAA for 5 min, suspensions spiral-plated 
on solid agar and incubated for 18h. Inadequate spore killing was observed at low concentrations 
(100 and 500 ppm) compared to controls, but complete sterility was seen at 1000 ppm and higher 
PAA concentrations. 
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Figure 4: PAA diluted in 20% ethanol effectively sterilizes spore-inoculated PCL scaffolds at 
1000 ppm in 15 min at room temperature. 
 
 
 
Figure shows scaffolds incubated in broth for 3 days on a mechanical shaker at 35oC. Lack of 
turbidity in broth for scaffolds treated with higher PAA concentrations (1000 ppm and above) 
indicates achievement of sterility. Low concentrations (100 ppm) and controls show incomplete 
spore inactivation and bacterial growth.   
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Figure 5:  Optical and scanning electron micrograph images to illustrate morphology changes of 
e-PCL scaffolds after sterilization treatments. 
 
 
 
EtO turned scaffolds into a solid, translucent film (dog-bone samples, placed in the same 
sterilization pouch, fused to the sheet) while autoclaving melted the scaffold. Complete loss of 
structure fibrous architecture can be observed with both standard sterilization methods. Chemical 
processing of scaffolds at room temperature (80% ethanol and PAA) did not induce any macro- 
or microscopic changes in scaffold morphology. 
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Figure 6:  SEM images of e-PCL scaffolds treated with different concentrations of PAA diluted 
in DI water (top) or 20% ethanol (bottom) for 15 min. 
 
 
 
Significant changes in the fibrous structure are seen when DI water was used as a diluent. Such 
effects were not observed in 20% ethanol group, even at 5000 ppm. 
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Figure 7:  Sessile drop images, after 10 s equilibration, on e-PCL scaffolds subjected to standard 
sterilization methods (A) and PAA diluted in DI water (B) or 20% ethanol (C).  
 
 
 
While conventional treatment reduced contact angles appreciably, PAA did not have any 
significant effect up to 2500 ppm. PAA at 5000 ppm induced a dramatic reduction in contact 
angle, irrespective of the diluent. The effect was more pronounced when 20% ethanol was used, 
as seen by complete absorption of the water drop. 
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Figure 8:  Quantification of contact angle measurements of PCL scaffolds from Figure 7. 
 
 
 
Significant reduction in contact angles were seen following treatment with PAA at 5000 ppm. 
PAA dilution in DI water reduces the contact angle by half, while dilution in 20% ethanol 
brought it to zero. 
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Figure 9:  Scaffold permeability (measured in darcy units) determined by flow rate of DI water 
through treated e-PCL scaffold.  
 
 
 
Decreased permeability was observed with increasing concentrations of PAA (p< 0.001) while 
EtO treated scaffolds formed a solid impermeable film. 
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Figure 10:  Mechanical properties of e-PCL scaffolds treated with different concentrations of 
PAA diluted in 20% ethanol.  
 
 
 
 
 
A. Tensile modulus, B. Strain at Break and C. Energy to Break.  Control scaffolds refer to 
scaffolds incubated with 20% ethanol with no PAA. Scaffolds treated with 80% ethanol 
are also shown. Scaffold properties were not significantly affected by PAA sterilization 
solution up to a concentration of 5000ppm. 
